Clinical trials
Observational Lymphoma, Large B-Cell, Diffuse trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
| Recruiting | 7 |
| Completed | 6 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 7 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Hoffmann-La Roche | 3 |
| Sun Yat-sen University | 3 |
| Fudan University | 2 |
| Peking University People's Hospital | 2 |
| Ting YANG | 2 |
| Chinese Academy of Medical Sciences | 1 |
| Jiangsu Cancer Institute & Hospital | 1 |
| Peking Union Medical College Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 29 |
| Lymphoma | 2 |
| Recurrence | 2 |
| Immunoblastic Lymphadenopathy | 1 |
| Lipodystrophy, Congenital Generalized | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.